Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml.
暂无分享,去创建一个
A. Partin | P. Walsh | J. Epstein | S. Freedland | E. Humphreys | D. Makarov | L. Mangold